glp-1 coverage medicare Drug New Medicare GLP-1 Bridge Program

Co-agonist strategy Glucose-dependent insulinotropic polypeptide (GIP) and glucagon receptor (GCGR) are currently the primary targets alongside GLP-1R for combined stimulation

The launch also expands potential use cases

Teduglutide (ALX-0600), a Dipeptidyl Peptidase IV Resistant Qlucagon-Like Peptide 2 Analogue, Improves Intestinal Function in Short Bowel Syndrome Patients

A medically guided switching protocol is crucial for safely and effectively transitioning between weight loss medications

Diabetes Care (2021) 44(Suppl 1):S11124

They are turning an enormous existing group, women aged 40 to 64 who already make up the majority of filler patients, into first-time cosmetic clients